Hyperglycemia and perioperative glucose management

Current Pharmaceutical Design

Volumn 18, Issue 38, 2012, Pages 6195-6203

  Duncan, Andra E ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetes; Glucose management; Hyperglycemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTIBIOTIC AGENT; D DIMER; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; GLUCOSE DERIVATIVE; GLUCOSE INSULIN POTASSIUM; HEPARIN; INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; MEGLITINIDE; METFORMIN; NATEGLINIDE; NITRIC OXIDE; ORAL ANTIDIABETIC AGENT; PHENFORMIN; REPAGLINIDE; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; DIET RESTRICTION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG INFUSION; DRUG MECHANISM; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOVOLEMIA; HYPOXEMIA; INDUCED HYPOTHERMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; ISCHEMIC PRECONDITIONING; KIDNEY FAILURE; LACTIC ACIDOSIS; META ANALYSIS; METABOLIC STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SOCIETY; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOCYTE AGGREGATION; VASODILATATION;

ALGORITHMS; BLOOD GLUCOSE; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; PATIENT SELECTION; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84873954920     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803832236     Document Type: Article

References (74)

1. an den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345(19): 1359-67.
2. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings 2003; 78(12): 1471-8.
3. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52(1): 20-8.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview. Stroke 2001 October 1, 2001; 32(10): 2426-32.
5. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355(9206): 773-8.
6. Outtara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005; 103(4): 687-94.
7. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thoracic & Cardiovascular Surgery 2005; 130(4): 1144-50.
8. Trick WE, Scheckler WE, Tokars JI, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thoracic Cardiovascular Surgery 2000; 119(1): 108-14.
9. Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010; 112(4): 860-71.
10. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England J Med 2008; 358(2): 125-39.
11. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35(10): 1738-48.
12. Investigators N-SS, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. New Eng J Med 2009; 360(13): 1283-97.
13. Cely CM, Arora P, Quartin AA, Kett DH, Schein RMH. Relationship of Baseline Glucose Homeostasis to Hyperglycemia During Medical Critical Illness. Chest 2004 September 1, 2004; 126(3): 879-87.
14. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opinion Clinical Nutrition Metabolic Care 1999; 2(1): 69-78.
15. Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia Analgesia 1999; 88(5): 1011-6.
16. Rassias AJ, Givan AL, Marrin CA, Whalen K, Pahl J, Yeager MP. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesthesia Analgesia 2002; 94(5): 1113-9.
17. Lefebvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabetic Med 1998; 15 Suppl 4: S63-8.
18. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 2000; 278(4): H1218-24.
19. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients.[see comment]. J Clinical Investigation 2005; 115(8): 2277-86.
20. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A. Insulin infusion in acute illness. J Clinical Investigation 2005; 115(8): 2069-72.
21. Collet JP, Montalescot G, Vicaut E, et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation 2003; 108(4): 391-4.
22. Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26(11): 3129-35.
23. Coggins M, Lindner J, Rattigan S, et al. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001; 50(12): 2682-90.
24. Laine H, Nuutila P, Luotolahti M, et al. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. J Clinical Endocrinol Metabol 2000; 85(5): 1868-73.
25. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002; 105(12): 1497-502.
26. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol-Heart Circulatory Physiol 2000; 278(4): H1345-51.
27. Hutter JF, Schweickhardt C, Piper HM, Spieckermann PG. Inhibition of fatty acid oxidation and decrease of oxygen consumption of working rat heart by 4-bromocrotonic acid. J Mol Cellular Cardiol 1984; 16(1): 105-8.
28. Kjekshus JK, Mjos OD. Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clinical Investigation 1972; 51(7): 1767-76.
29. de Leiris J, Opie LH. Effect of substrates and of coronary artery ligation on mechanical performance and on release of lactate dehydrogenase and creatine phosphokinase in isolated working rat hearts. Cardiovascular Res 1978; 12(10): 585-96.
30. Opie LH, Owen P, Riemersma RA. Relative rates of oxidation of glucose and free fatty acids by ischaemic and non-ischaemic myocardium after coronary artery ligation in the dog. Eur J Clinical Investigation 1973; 3(5): 419-35.
31. Fath-Ordoubadi F, Beatt KJ. Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction: An Overview of Randomized Placebo-Controlled Trials. Circulation 1997; 96(4): 1152-6.
32. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314(7093): 1512-5.
33. Bothe W, Olschewski M, Beyersdorf F, Doenst T. Glucose-insulinpotassium in cardiac surgery: a meta-analysis. Ann Thoracic Surgery 2004; 78(5): 1650-7.
34. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulinpotassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293(4): 437-46.
35. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26(7): 650-61.
36. Bruemmer-Smith S, Avidan MS, Harris B, et al. Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesthesia 2002; 88(4): 489-95.
37. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007-21.
38. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-62.
39. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154(4): 260-7.
40. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings 2005; 80(7): 862-6.
41. Garber AJ, Moghissi ES, Bransome ED, Jr., et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocrine Practice 2004; 10 Suppl 2: 4-9.
42. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300(8): 933-44.
43. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. JACC 1999; 33(1): 119-24.
44. Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994; 90(2): 700-5.
45. Gu W, Pagel PS, Warltier DC, Kersten JR. Modifying cardiovascular risk in diabetes mellitus. Anesthesiology 2003; 98: 774-9.
46. Bailey CJ, Turner RC. Drug therapy: Metformin. N Engl J Med 1996; 334(9): 574-9.
47. Mears SC, Lipsett PA, Brager MD, Riley LH. Metforminassociated lactic acidosis after elective cervical spine fusion. Spine 2002; 27: E482-E4.
48. Mercker SK, Maier C, Neumann G, Wulf H. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology 1997; 87(4): 1003-5.
49. Duncan AI, Koch CG, Xu M, et al. Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesthesia Analgesia 2007; 104(1): 42-50.
50. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55(11): 3151-9.
51. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clinic Proceedings 2005; 80(12): 1558-67.
52. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Seminars Thoracic Cardiovascular Surgery 2006; 18(4): 317-25.
53. Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Critical Care Medicine 2008; 36(8): 2249-55.
54. Lehot JJ, Piriz H, Villard J, Cohen R, Guidollet J. Glucose homeostasis. Comparison between hypothermic and normothermic cardiopulmonary bypass. Chest 1992; 102(1): 106-11.
55. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesthesia Analgesia 2004; 99(2): 319-24.
56. Lee KU, Lee HK, Koh CS, Min HK. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 1988; 31(5): 285-90.
57. Werb MR, Zinman B, Teasdale SJ, Goldman BS, Scully HE, Marliss EB. Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clinical Endocrinol Metabol 1989; 69(5): 1010-8.
58. Van den Berghe G. Does tight blood glucose control during cardiac surgery improve patient outcomes? Ann Intern Med 2007; 146(4): 307-8.
59. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Internal Med 2007; 146(4): 233-43.
60. Subramaniam B, Panzica PJ, Novack V, et al. Continuous Perioperative Insulin Infusion Decreases Major Cardiovascular Events in Patients Undergoing Vascular Surgery: A Prospective, Randomized Trial. Anesthesiology 2009; 110(5): 970-7
61. Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009; 110(3): 611-9.
62. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Failure Rev 2002; 7(2): 115-30.
63. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999; 99(4): 578-88.
64. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295(14): 1681-7.
65. Egi M, Rinaldo B, Stachowski E, French C, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105(2): 244-52.
66. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Critical Care 2009; 13: R91.
67. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Critical Care Medicine 2008; 36(11): 3008-13.
68. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. New Eng J Med 2006; 354(5): 449-61.
69. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011; 154(4): 268-82.
70. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35(10): 2262-7.
71. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15(4): 353-69.
72. Furnary AP, Wu YX, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland diabetic project. Endocr Pract 2004; 10[Suppl 2]: 21-33.
73. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009; 87(2): 663-9.
74. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care 2006; 10(1): R19.